Skip to main navigation Skip to search Skip to main content

Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours

  • David S. Hong
  • , Yoon Koo Kang
  • , Mitesh Borad
  • , Jasgit Sachdev
  • , Samuel Ejadi
  • , Ho Yeong Lim
  • , Andrew J. Brenner
  • , Keunchil Park
  • , Jae Lyun Lee
  • , Tae You Kim
  • , Sangjoon Shin
  • , Carlos R. Becerra
  • , Gerald Falchook
  • , Jay Stoudemire
  • , Desiree Martin
  • , Kevin Kelnar
  • , Heidi Peltier
  • , Vinicius Bonato
  • , Andreas G. Bader
  • , Susan Smith
    • Sinil Kim, Vincent O’Neill, Muhammad S. Beg
  • University of Texas MD Anderson Cancer Center
  • University of Ulsan
  • Mayo Clinic Scottsdale-Phoenix, Arizona
  • HonorHealth, Arizona
  • University of California at Irvine
  • University of Texas Health Science Center at San Antonio
  • Seoul National University
  • Yonsei University
  • Baylor Health Care System
  • HealthOne
  • Synlogic
  • University of Texas Southwestern Medical Center

Research output: Contribution to journal › Article › peer-review

857   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science